{
    "organizations": [],
    "uuid": "e4fb6f2835bc5908483e3f335ceac05f183808bd",
    "author": "",
    "url": "https://www.reuters.com/article/brief-seattle-genetics-says-if-deal-term/brief-seattle-genetics-says-if-deal-terminated-under-cascadian-therapeutics-to-pay-fee-of-17-million-idUSFWN1PQ0TI",
    "ord_in_thread": 0,
    "title": "BRIEF-Seattle Genetics Says If Deal Terminated Under, Cascadian Therapeutics To Pay Fee Of $17 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 26 PM / in 14 minutes BRIEF-Seattle Genetics Says If Deal Terminated Under, Cascadian Therapeutics To Pay Fee Of $17 Million   \nJan 31 (Reuters) - Seattle Genetics Inc: \n* SEATTLE GENETICS SAYS IF DEAL TERMINATED UNDER CERTAIN CIRCUMSTANCES, CASCADIAN THERAPEUTICS MAY BE REQUIRED TO PAY CO FEE OF $17 MILLION - SEC FILING Source text: ( bit.ly/2E2RNXK ) Further company coverage:",
    "published": "2018-01-31T14:25:00.000+02:00",
    "crawled": "2018-01-31T14:47:10.030+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "genetics",
        "say",
        "deal",
        "terminated",
        "cascadian",
        "therapeutic",
        "pay",
        "fee",
        "million",
        "jan",
        "reuters",
        "seattle",
        "genetics",
        "inc",
        "seattle",
        "genetics",
        "say",
        "deal",
        "terminated",
        "certain",
        "circumstance",
        "cascadian",
        "therapeutic",
        "may",
        "required",
        "pay",
        "co",
        "fee",
        "million",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}